Replay available

Integrated Diagnostics Holdings plc (IDHC) Q3 2025 Earnings Call

Integrated Diagnostics Holdings plc (LSE: IDHC) Q3 2025 earnings conference call, held 2025-11-25. Replay captured from the company's public earnings webcast.

Tue, November 25, 2025 at 8:00 AMendedReplay
Integrated Diagnostics Holdings plc (IDHC) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Webinar System

Automated Recording Notice

Tariq Yahya

Director of Investor Relations

Dr. Hindul Shirbini

Chief Executive Officer

Sharif El-Zaini

Vice President and Group CFO

Ali Nasser

Analyst

Unnamed IDH Representative

Corporate Finance Specialist

Replay transcript excerpt

Webinar is being recorded and summarized. Hello, everyone. This is Ahmed Mathez from UFJMS, and welcome to IDH's third quarter of 25 results conference call. I'm pleased to be joined with Dr. Hendra Shirvini, Chief Executive Officer, Shriviraj Bilzaini, Vice President and Group CFO, and Tara Yahya, Director of Investor Relations. The company, as usual, will start with a brief presentation, and then we'll open the floor for Q&A. IDH management, please go ahead. Thank you, Ahmed. Good afternoon, ladies and gentlemen, and thank you for joining us for our third quarter underscore. My name is Tariq Yahya. I'm head of Investor Relations. Joining me today, Dr. Hindul Shirbini, our CEO, Mr. Sharif El-Zaini, our CFO and VP. Dr. Hindul begins the call with a summary of latest period main highlights. After that, I will discuss in more details the main macroeconomics and geopolitical trends seen across our markets. Then, after my presentation, Mr. Sharif will offer a deeper analysis of our financial performance. Then we will open for Q&A. Dr. Hande will start now. Thank you. Thank you, Tarek, and good afternoon, everyone. I'm Dr. Hande Sherbini, CEO of IDH. As we approach the end of what has been another very strong year for the group, I'm pleased to report a robust set of results for the first nine months of 2025. The performance we are presenting today reflects not only healthy market dynamics, but also the tangible results of the strategic initiatives we have been implementing over the past two years, particularly around network and geographic expansion, operational optimization, digitization, and service diversification. Throughout the year, we have continued to strengthen our core business in Egypt and Jordan, while making pronounced progress in newer markets, namely Nigeri...

More from Integrated Diagnostics Holdings Plc